Cresp (Darbepoetin alfa) Injection is a prescription drug used to treat anemia due to chronic kidney disease or due to chemotherapy. Cresp 40mcg injection is an erythropoiesis-stimulating agent (ESA). It Stimulates bone marrow to produce more red blood cells.
Manufacturer : Dr Reddy's Laboratories Ltd.
Strengths available : 25mcg, 40mcg, 60mcg, 100mcg & 200mcg
Storage : Store at temperature between 2°C - 8°C
Dosage :
Renal Anemia: Hemodialysis Patients:
The usual dose of Cresp in adult patients is 20 ?g as Cresp (genetical recombination), to be administered as a single intravenous injection once weekly.
Peritoneal Dialysis Patients And Patients With Chronic Kidney Disease Not On Dialysis:
The usual dose of Cresp in adult patients is 30 ?g as Cresp (genetical recombination), to be administered as a single injection once every two weeks subcutaneously or intravenously.
Treatment of Anemia in Cancer Patients Receiving Myelosuppressive Chemotherapy:
Initiate Cresp in patients on cancer chemotherapy only if the hemoglobin is less than 10 g/dL, and if there is a minimum of two additional months of planned chemotherapy.
Common side effects are Increased blood pressure, Hypersensitivity.
Pack of 1 Vial
Mehan Biosciences is a WHO GDSP approved & licensed Pharmaceutical stockist/wholesaler/distributor/exporter/importer of CRESP Darbepoetin Alfa Injection based in India - To buy CRESP Darbepoetin Alfa Injection or know its cost price contact us here.
We supply & sell CRESP Darbepoetin Alfa Injection for Reference Listed Drugs, Government Tenders, Shortage Lists, Emergency Imports, Name Patient Drugs, Comparator Drug Studies, Un-licensed Importation, clinical trial samples & Bio-Similars.
At MBS, we acknowledge the critical role that reliable sourcing and timely delivery play in the healthcare industry. MBS is your trusted partner in pharmaceutical supply chain management.